RECRUITING

CHOICES-TEEN Randomized Controlled Trial

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This randomized controlled trial will: 1) Test the efficacy of the CHOICES-TEEN (CT) intervention compared with an Attentional Control (AC) condition on reducing the risk of substance-exposed pregnancy (SEP) and HIV/STI among high-risk female youth involved with the juvenile justice system by reducing alcohol use, increasing marijuana cessation, reducing risk of pregnancy, and increasing condom use; 2) Test the efficacy of CT, compared to AC, on increasing cognitive self-regulation abilities; 3) Test proposed intervention mediators/mechanisms of action for CT overall and by race/ethnicity; and 4) Test the moderating effect of initial readiness to change on risk of SEP and risk of HIV/STI.

Official Title

CHOICES-TEEN: Efficacy of a Bundled Risk Reduction Intervention for Juvenile Justice Females

Quick Facts

Study Start:2022-04-08
Study Completion:2026-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05368571

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:14 Years to 19 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * sexual intercourse with a male
  2. * inconsistent/ineffective condom use AND
  3. * inconsistent/ineffective contraception use
  1. * severe cognitive and/or psychiatric impairment that precludes cooperation with study protocol, per judgement of the interventionist or research staff
  2. * do not speak or read/write in English
  3. * unable to meet study requirements, including follow-up assessments

Contacts and Locations

Study Contact

Danielle E Parrish, Ph.D.
CONTACT
346-701-8047
danielle_parrish@baylor.edu
Kirk L von Sternberg, Ph.D.
CONTACT
512-232-0633
vonsternberg@mail.utexas.edu

Principal Investigator

Danielle E Parrish, Ph.D.
PRINCIPAL_INVESTIGATOR
Baylor University
Kirk L von Sternberg, Ph.D.
PRINCIPAL_INVESTIGATOR
University of Texas at Austin

Study Locations (Sites)

Baylor University
Houston, Texas, 77002
United States

Collaborators and Investigators

Sponsor: Baylor University

  • Danielle E Parrish, Ph.D., PRINCIPAL_INVESTIGATOR, Baylor University
  • Kirk L von Sternberg, Ph.D., PRINCIPAL_INVESTIGATOR, University of Texas at Austin

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-04-08
Study Completion Date2026-03

Study Record Updates

Study Start Date2022-04-08
Study Completion Date2026-03

Terms related to this study

Additional Relevant MeSH Terms

  • Risk for an Alcohol-Exposed Pregnancy
  • Risk for Marijuana-Exposed Pregnancy
  • Risk for Substance-Exposed Pregnancy
  • HIV Risk
  • Sexually Transmitted Infection Risk